Previous studies from our laboratory demonstrated that heterozygous expression of p190B, a major regulator of Rac and RhoA [15,16], potently inhibited tumor formation and metastases in the MMTV-Neu mouse mammary tumor model [17]. Here, ERBB2 is linked to breast cancer.